2026 Phillip K. Darcy: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	87	1217	1105	42	40	359	25264
Medicine	87	13736	12925	453	442	503	25292

Overview

Phillip K. Darcy is affiliated with the Peter MacCallum Cancer Centre in Australia. Their primary fields of study are Medicine and Immunology and Microbiology, with significant contributions across related subfields such as Oncology, Immunology, Molecular Biology, Genetics, and Pulmonary and Respiratory Medicine.

The main topics covered in their research include:

CAR-T cell therapy research
Immune Cell Function and Interaction
Cancer Immunotherapy and Biomarkers
Immunotherapy and Immune Responses
Viral Infectious Diseases and Gene Expression in Insects
Immune cells in cancer
CRISPR and Genetic Engineering

Their publication record includes notable papers such as:

"Cellular networks controlling T cell persistence in adoptive cell therapy" (2021) published in Nature Reviews. Immunology
"Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity" (2020) published in Nature Immunology
"CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy" (2021) published in Nature Communications
"Intratumoral CD8+ T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer" (2023) published in Cancer Cell
"FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy" (2024) published in Nature

The venues where Phillip K. Darcy has frequently published include:

Regular and Young Investigator Award Abstracts
Nature Communications
Cytotherapy
Cancer Cell
Journal of Clinical Oncology

Frequent collaborators in their research include:

Paul J. Neeson
Paul A. Beavis
Kevin Sek
Joseph A. Trapani
Imran G. House

Phillip K. Darcy's work spans multidisciplinary areas involving cellular therapies, immunotherapy mechanisms, and genetic engineering approaches such as CRISPR. Their research on CAR-T cell therapies is especially prominent, reflecting sustained interest in enhancing immune system function to target cancer effectively.

Best Publications

Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis

Peter Savas;Balaji Virassamy;Chengzhong Ye;Agus Salim;Agus Salim

1000
Citations
Clinical relevance of host immunity in breast cancer: from TILs to the clinic

Peter Savas;Roberto Salgado;Carsten Denkert;Christos Sotiriou

945
Citations
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity

Marian L Burr;Marian L Burr;Marian L Burr;Christina E Sparbier;Yih-Chih Chan;James C Williamson

930
Citations
Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells

Liza B John;Christel Devaud;Connie P M Duong;Carmen S M Yong

781
Citations
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.

Imran G House;Imran G House;Peter Savas;Peter Savas;Junyun Lai;Junyun Lai;Amanda X. Y. Chen;Amanda X. Y. Chen

697
Citations
Gene-engineered T cells for cancer therapy

Michael H Kershaw;Jennifer A Westwood;Phillip K Darcy;Phillip K Darcy

675
Citations
Activating and inhibitory receptors of natural killer cells.

Hollie J Pegram;Daniel M Andrews;Mark J Smyth;Phillip K Darcy

663
Citations
RAS/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: therapeutic cooperation between MEK and PD-1/PD-L1 immune checkpoint inhibitors

Sherene Loi;Sherene Loi;Sathana Dushyanthen;Paul A. Beavis;Roberto Salgado

653
Citations
Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape.

Leisha A. Emens;Paolo A. Ascierto;Phillip K. Darcy;Sandra Demaria

597
Citations
CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer

Sherene Loi;Sandra Pommey;Benjamin Haibe-Kains;Paul A Beavis

555
Citations
Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemia.

David S. Ritchie;Paul J. Neeson;Paul J. Neeson;Amit Khot;Stefan Peinert

512
Citations
Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection.

Janice M Kelly;Phillip K Darcy;Jessica L Markby;Dale I Godfrey

488
Citations
Trafficking of T Cells into Tumors

Clare Y. Slaney;Clare Y. Slaney;Michael H. Kershaw;Phillip K. Darcy

472
Citations
CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis

John Stagg;Upulie Divisekera;Helene Duret;Tim Sparwasser

443
Citations
CD73: a potent suppressor of antitumor immune responses

Paul. A. Beavis;John Stagg;Phillip K. Darcy;Phillip K. Darcy;Mark J. Smyth;Mark J. Smyth

420
Citations
Tumor immune evasion arises through loss of TNF sensitivity

Conor J. Kearney;Conor J. Kearney;Stephin J. Vervoort;Stephin J. Vervoort;Simon J. Hogg;Simon J. Hogg;Kelly M. Ramsbottom

382
Citations
Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors

Paul A. Beavis;Upulie Divisekera;Upulie Divisekera;Christophe Paget;Christophe Paget;Melvyn T. Chow;Melvyn T. Chow

374
Citations
Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity.

A J Davenport;R S Cross;R S Cross;K A Watson;Y Liao

347
Citations
Combined immune checkpoint blockade as a therapeutic strategy for BRCA1-mutated breast cancer.

Emma Nolan;Emma Nolan;Peter Savas;Peter Savas;Antonia N. Policheni;Antonia N. Policheni;Phillip K. Darcy;Phillip K. Darcy

324
Citations
Adenosine Receptor 2A Blockade Increases the Efficacy of Anti–PD-1 through Enhanced Antitumor T-cell Responses

Paul A. Beavis;Paul A. Beavis;Nicole Milenkovski;Nicole Milenkovski;Melissa A. Henderson;Melissa A. Henderson;Liza B. John;Liza B. John

316
Citations
A network of PDZ-containing proteins regulates T cell polarity and morphology during migration and immunological synapse formation.

Mandy J. Ludford-Menting;Jane Oliaro;Faruk Sacirbegovic;Eric T.-Y. Cheah

314
Citations
Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy

Paul A. Beavis;Paul A. Beavis;Melissa A. Henderson;Melissa A. Henderson;Lauren Giuffrida;Lauren Giuffrida;Jane K. Mills;Jane K. Mills

314
Citations

Frequent Co-Authors

Michael H. Kershaw Peter MacCallum Cancer Centre

Mark J. Smyth QIMR Berghofer Medical Research Institute

Paul A. Beavis Peter MacCallum Cancer Centre

Joseph A. Trapani Peter MacCallum Cancer Centre

Sherene Loi Peter MacCallum Cancer Centre

Robert G. Ramsay Peter MacCallum Cancer Centre

Michele W. L. Teng QIMR Berghofer Medical Research Institute

Ricky W. Johnstone Peter MacCallum Cancer Centre

David Ritchie Peter MacCallum Cancer Centre

Ilia Voskoboinik Peter MacCallum Cancer Centre

External Links

Personal website of Phillip K. Darcy

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond Immunology, pursuing a career in nursing offers diverse opportunities, especially through specialized programs. Transitioning into roles like an acute care nurse practitioner is a popular pathway, with several acute care nurse practitioner programs designed to build advanced clinical skills.

Many students find value in accelerated pathways that expedite their journey into healthcare professions. Online options, such as the accelerated nurse practitioner program, provide flexible learning formats ideal for those looking to shift careers quickly.

For individuals without a nursing background, several options exist to enter the field efficiently. Programs like online accelerated nursing programs for non nurses offer tailored curricula to build foundational knowledge while accelerating degree completion.

Furthermore, some students prioritize accessibility and ease of admission. Exploring the easiest accelerated nursing programs can help identify institutions that match these criteria without compromising educational quality.